As of January 30, 2026, Swissmedic has updated its guidelines for the maintenance of medical devices,…
Category: Switzerland
Switzerland updates on medical device regulation and quality.
Swissmedic Authorises Obgemsa: What It Means for Medical Device Manufacturers
As of 30 January 2026, Swissmedic has granted authorisation for Obgemsa, marking a significant milestone in…
Swissmedic Authorises Alyftrek: What You Need to Know
Alyftrek Receives First Authorisation As of 30 January 2026, Alyftrek has been granted its first authorisation…
Swissmedic Intensifies Market Surveillance of Medical Devices: Key Takeaways for Importers
Swissmedic, the Swiss Agency for Therapeutic Products, has conducted a focus campaign on importers of medical…
Swissmedic Introduces Mandatory Quality Standards for Pharmaceuticals: What You Need to Know
The Swiss Agency for Therapeutic Products, Swissmedic, has announced a significant shift in the regulatory landscape…
Swissmedic Approves Extension of Therapeutic Indication for Nubeqa
PUBLISHED: January 29, 2026 Swissmedic has announced the approval of an extension of therapeutic indication for…
Ocrevus Liver Damage: Swissmedic Update on Ocrelizumab Risks
On January 28, 2026, Swissmedic released a statement regarding Ocrevus (ocrelizumab), a medication used to treat…
Swissmedic Approves Extension of Therapeutic Indication for Hepcludex
On January 27, 2026, Swissmedic announced the extension of the therapeutic indication for Hepcludex, a medication…
Swissmedic Expands Indication for Amvuttra
Published January 26, 2026 The Swiss Agency for Therapeutic Products (Swissmedic) announced an extension of the…
Swissmedic Introduces New Requirements for Integral Combination Products
On January 21, 2026, Swissmedic announced new requirements for the authorization of medicinal products with integral…